Management of Cardiac Sarcoidosis in 2020

Nisha Gilotra1, David Okada1, Apurva Sharma1

  • 1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, US.

Insights

Cardiac sarcoidosis (CS) is an inflammatory condition affecting the heart, presenting with arrhythmias and heart failure. Advanced imaging aids diagnosis, while updated management focuses on immunosuppression and targeted therapies.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Sarcoidosis is a multisystem inflammatory disease.
  • Cardiac involvement occurs in up to 25% of systemic sarcoidosis patients.
  • Cardiac sarcoidosis (CS) presents with diverse clinical manifestations.

Purpose of the Study:

  • To provide an update on the diagnosis and management of cardiac sarcoidosis.
  • To review clinical manifestations, diagnostic imaging, and therapeutic strategies for CS.
  • To identify knowledge gaps and future research directions in CS.

Main Methods:

  • Review of current literature on cardiac sarcoidosis diagnosis and management.
  • Emphasis on the role of advanced cardiac imaging in identifying CS.
  • Discussion of updated treatment protocols including immunosuppression and supportive therapies.

Main Results:

  • Diagnosis of CS is improving with advanced cardiac imaging.
  • Clinical manifestations include heart block, arrhythmias, and heart failure.
  • Corticosteroids are standard, with evolving roles for steroid-sparing agents.

Conclusions:

  • Early diagnosis and management of CS are crucial.
  • Multidisciplinary approach is essential for optimal patient outcomes.
  • Further research is needed to refine treatment strategies and address knowledge gaps.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
108
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
200
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
154
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149